| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/28/2009 | CN101352438A Uses of deferiprone and formulation thereof in preparing medicament for preventing and treating cardiotoxicity induced by anthracyclines |
| 01/28/2009 | CN101352433A Formulation capable of effectively balancing blood pressure, blood fat and promoting cardio-cerebral arterial vascular softening, and preparation method thereof |
| 01/28/2009 | CN101352430A Compound formulation containing carthamus tinctorius yellow colour B and uses thereof |
| 01/28/2009 | CN101352429A Use of tiopronin in preparing medicament for treating liver function damage induced by cerebral ischemia, diabetes and obesity |
| 01/28/2009 | CN101352421A Method for preparing basically non-crystalline type telmisartan |
| 01/28/2009 | CN101352411A Nimodipine solid dispersed formulation and preparation method thereof |
| 01/28/2009 | CN101352253A Compound beverage containing collard, red date, haw thorn and chrysanthemum |
| 01/28/2009 | CN100455595C Protein of interreaction with karyomitosis primary activator protein kinase p38 and its coding gene and application |
| 01/28/2009 | CN100455571C Kukoline salt compounds and its preparation method |
| 01/28/2009 | CN100455568C 6-position substituted indoline, production and use thereof as medicament |
| 01/28/2009 | CN100455566C Novel derivatives of aminocyclohexane |
| 01/28/2009 | CN100455316C Use of medicinal composition containing ligusticum wallichii for treating chronic brain blood supply deficiency |
| 01/28/2009 | CN100455315C Injecting Mailuoning, its preparation and quality control thereof |
| 01/28/2009 | CN100455303C Ultrasonic extraction technology of xiasangju |
| 01/28/2009 | CN100455302C Danshen freeze-drying injection for treating cardiovascular and cerebrovascular diseases and preparation thereof |
| 01/28/2009 | CN100455301C Therapeutical use of sophora flavescens or sophora subprostrated extracts |
| 01/28/2009 | CN100455291C Notoginseng medicine composition for treating cardiac and cerebral vascular diseases |
| 01/28/2009 | CN100455290C Novel receptors for dollar i(helicobacter pylori) and use thereof |
| 01/28/2009 | CN100455288C Formula of Reynoldazine hydrochloride prepn. |
| 01/27/2009 | US7482484 Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia |
| 01/27/2009 | US7482472 Such as 2-(4-[[(5-chloro-2-thienyl)carbonyl]amino]-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid; blood coagulation; treating thromboembolic disorders (myocardial infarction, angina pectoris, reocclusions and restenoses after angioplasty/aortocoronary bypass, stroke), atherosclerosis and arthritis |
| 01/27/2009 | US7482434 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 01/27/2009 | US7482373 useful in the treatment of central or peripheral nervous system disorders; psychological disorders; gastrointestinal disorders |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482369 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/27/2009 | US7482368 Triamide-substituted heterobicyclic compounds |
| 01/27/2009 | US7482365 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases |
| 01/27/2009 | US7482363 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
| 01/27/2009 | US7482355 Pyrimidine derivatives as modulators of chemokine receptor activity |
| 01/27/2009 | US7482340 Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
| 01/27/2009 | US7482331 Treating myocardial failure in a human by administering an effective amount of a transgene encoding for alpha-MHC, wherein expression of alpha-MHC provides improvement in left ventricular ejection fraction |
| 01/27/2009 | US7482321 Extended glucagon-like peptide-1 analogs |
| 01/27/2009 | US7482320 Modulation of smooth muscle cell proliferation |
| 01/27/2009 | US7482024 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | US7482003 Also for treatment of inflammatory bowel disease; humanized heavy/light chains; complementary determining regions |
| 01/27/2009 | CA2430696C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 01/27/2009 | CA2416403C A medicinal aerosol formulation |
| 01/27/2009 | CA2415442C Novel .beta. crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same |
| 01/27/2009 | CA2388646C Methods and compositions utilizing quinazolinones |
| 01/27/2009 | CA2380757C Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 01/27/2009 | CA2377226C Benzimidazole compounds and medicaments comprising the same |
| 01/27/2009 | CA2377126C Thiazole and oxazole derivatives and their pharmaceutical use |
| 01/27/2009 | CA2290520C Inhibition of p38 kinase activity by aryl ureas |
| 01/27/2009 | CA2285040C Death domain containing receptor 5 |
| 01/27/2009 | CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 01/27/2009 | CA2235372C Method for treating ischemic tissue |
| 01/27/2009 | CA2045869C Fusion proteins with immunoglobulin portions, the preparation and use thereof |
| 01/26/2009 | CA2637979A1 Treatment of cardiovascular disease in mexican americans using nebivolol |
| 01/22/2009 | WO2009012223A1 Compositions for the treatment of metabolic disorders |
| 01/22/2009 | WO2009011617A2 ANNELATED AZAHETEROCYCLES COMPRISING PYRIMIDINE FRAGMENT, METHOD FOR THE PRODUCTION THEREOF AND (PI3Ks) KINASE INHIBITORS |
| 01/22/2009 | WO2009011285A1 Heteroarylbenzene compounds |
| 01/22/2009 | WO2009011112A1 Stable fat emulsion containing prostaglandin e1 |
| 01/22/2009 | WO2009010488A1 Heterocyclic compounds useful as mk2 inhibitors |
| 01/22/2009 | WO2009010429A2 Novel heterocyclyl compounds and their use as chemokine antagonists |
| 01/22/2009 | WO2009009829A1 Method for reducing intracranial pressure |
| 01/22/2009 | WO2008076447A3 Treatments of therapy-resistant diseases comprising drug combinations |
| 01/22/2009 | US20090023900 Anti-AlphaVBeta3 Recombinant Human Antibodies, Nucleic Acids Encoding Same |
| 01/22/2009 | US20090023802 liquid-crystal media used in electro-optical displays; treatment or prophylaxis of diseases or symptoms which can be influenced by inhibition of cannabinoid receptors |
| 01/22/2009 | US20090023800 Cannabinoid receptor modulator |
| 01/22/2009 | US20090023789 N-[(5Z)-4-butyl-2-tert-butylisothiazol-5(2H)-ylidene]-5-chloro-2-methoxybenzamide; CB2 receptors ligand; antiinflammatory, analgesic agent; autoimmune diseases; neuroprotectants |
| 01/22/2009 | US20090023781 Haloalkyl Containing Compounds as Cysteine Protease Inhibitors |
| 01/22/2009 | US20090023777 Substituted 4-amino-benzylpiperidine compounds |
| 01/22/2009 | US20090023775 1-[2-(4-benzyl-4-hydroxy-piperidin-1 -yl )-ethyl]-3-(2-methyl-quinolin- 4-yl)- urea as crystalline sulfate salt |
| 01/22/2009 | US20090023774 Pyridine analogs as C5A antagonists |
| 01/22/2009 | US20090023770 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors |
| 01/22/2009 | US20090023769 Organic Compounds |
| 01/22/2009 | US20090023763 Condensed Pyridine Derivatives Useful as A2B Adenosine Receptor Antagonists |
| 01/22/2009 | US20090023749 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; psychiatric disorders; sexual dysfunctions; fibromyalgia |
| 01/22/2009 | US20090023742 Thiazolones for use as pi3 kinase inhibitors |
| 01/22/2009 | US20090023739 Capase inhibitors and uses thereof |
| 01/22/2009 | US20090023731 Soluble epoxide hydrolase inhibitors |
| 01/22/2009 | US20090023729 Trisubstituted amine compound |
| 01/22/2009 | US20090023716 Benzoxazines and Related Nitrogen-Containing Heterobicyclic Compounds Useful as Mineralocorticoid Receptor Modulating Agents |
| 01/22/2009 | US20090023714 Combined preparation of a thiazide diuretic and a loop diuretic |
| 01/22/2009 | US20090023702 Pyridone gpr119 g protein-coupled receptor agonists |
| 01/22/2009 | US20090023692 Compositions for inhibiting and preventing vascular occlusion containing nutritional supplements |
| 01/22/2009 | US20090023691 Delaying the ageing process and disorders caused by ageing |
| 01/22/2009 | US20090023658 Neovascularization Inhibitors Derived From HGF and Methods Involving the Same |
| 01/22/2009 | US20090023649 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 01/22/2009 | US20090023647 Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
| 01/22/2009 | US20090023644 Methods of using cgrp for cardiovascular and renal indications |
| 01/22/2009 | US20090023643 Methods For Treating Acute Myocardial Infarction By Administering Calcitonin Gene Related Peptide And Compositions Containing The Same |
| 01/22/2009 | US20090023640 Use Of A Cyclic Undecapeptide For The Preparation Of A Medicament For Administration During Myocardial Ischaemic Events |
| 01/22/2009 | US20090023639 Methods of Treatment |
| 01/22/2009 | US20090023635 Factor VII or VIIa - Like Molecules |
| 01/22/2009 | US20090023633 Regulation of mineral and skeletal metabolism |
| 01/22/2009 | US20090023228 Dual-acting Imidazole antihypertensive agents |
| 01/22/2009 | US20090023224 Vascular endothelial growth factor 2 |
| 01/22/2009 | US20090023216 Double-Stranded Oligonucleotides |
| 01/22/2009 | US20090023184 Novel Tachykinin Peptides, Precursor Peptides Thereof And Genes Encoding The Same |
| 01/22/2009 | US20090022828 Methods and compositions for inhibiting angiotensin converting and chymase enzymes |
| 01/22/2009 | US20090022817 Methods of modifying myocardial infarction expansion |
| 01/22/2009 | US20090022802 Cardiomyopathy therapeutic agent |
| 01/22/2009 | US20090022774 Methods of administering tetrazole-containing rapamycin analogs with other therapeutic substances for treatment of vascular disorder |
| 01/22/2009 | US20090022743 Peptides Effective in the Treatment of Tumors and Other Conditions Requiring the Removal or Destruction of Cells |
| 01/22/2009 | US20090022733 Methods for treating Disease with an IL-1R antibody |
| 01/22/2009 | US20090022724 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 01/22/2009 | US20090022718 Methods of treating a blood pathology using anti-TNF antibodies and fragments thereof |
| 01/22/2009 | US20090022694 Sirt1 inhibition |